Therapeutic efficacy of rituximab combined with cyclosporin A on B-cell dysregulation in chronic graft-versus-host disease

Chronic graft-versus-host disease (cGVHD) is a significant complication following allogenic hematopoietic stem cell transplantation, often necessitating therapeutic interventions such as rituximab (RTX) and cyclosporin A (CsA). This study aims to elucidate the mechanisms by which RTX and CsA jointly...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical & translational oncology 2024-09
Hauptverfasser:	Fu, Xiang-Jun, Meng, Can, Guo, Li, Lin, Li-E
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!